# Ingenus Pharmaceuticals NJ, LLC. - Inspection Records

Source: https://www.keypedia.com/companies/ingenus-pharmaceuticals-nj-llc/542b7622-3ecf-48db-9fc6-0edf6cc42665

> Inspection records and compliance data for Ingenus Pharmaceuticals NJ, LLC. in Fairfield, New Jersey. Access full analysis and detailed observations.

---

## Details

- Name: Ingenus Pharmaceuticals NJ, LLC.
- FEI Number: 2246963
- City: Fairfield
- State: New Jersey
- Country Name: United States
- Address Line 1: 140 New Dutch Ln
- Zip Code: 07004
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1302128 - Ingenus Pharmaceuticals NJ, LLC. - 2026-01-09](https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-nj-llc/fd51015b-b7df-4717-89ae-a01d870978ed) — source: FDA, date: January 9, 2026
- [FDA Inspection 1302128 - Ingenus Pharmaceuticals NJ, LLC. - 2026-01-09](https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-nj-llc/28085f92-d1d5-4bf4-b779-62ca9a37c77e) — classification: No Action Indicated (NAI), source: FDA, date: January 9, 2026
- [FDA Inspection 1164226 - Ingenus Pharmaceuticals NJ, LLC. - 2022-02-18](https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-nj-llc/ced16e83-e2b7-4b69-8454-09af242a3c4f) — classification: No Action Indicated (NAI), source: FDA, date: February 18, 2022
- [FDA Inspection 1079060 - Ingenus Pharmaceuticals NJ, LLC. - 2019-01-24](https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-nj-llc/932a2aa0-0f09-4557-bbe1-22bde883936c) — classification: No Action Indicated (NAI), source: FDA, date: January 24, 2019
- [EIR - Ingenus Pharmaceuticals NJ, LLC. - 2017-12-14](https://www.keypedia.com/records/eir/ingenus-pharmaceuticals-nj-llc/75370105-2eb3-4c1e-8bc2-f7de0c9c236f) — source: FDA, date: December 14, 2017
- [483 - Ingenus Pharmaceuticals NJ, LLC. - 2017-12-14](https://www.keypedia.com/records/483/ingenus-pharmaceuticals-nj-llc/21cba86e-7fa7-4b9f-8704-78ed9dd9ebe2) — source: FDA, date: December 14, 2017
- [FDA Inspection 1026727 - Ingenus Pharmaceuticals NJ, LLC. - 2017-09-27](https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-nj-llc/fe279523-321a-41c0-818b-f4219e00517d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 27, 2017
- [FDA Inspection 994493 - Ingenus Pharmaceuticals NJ, LLC. - 2016-11-16](https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-nj-llc/5d1df4e8-5227-405a-9c31-2c3dadb2f958) — classification: No Action Indicated (NAI), source: FDA, date: November 16, 2016
- [FDA Inspection 924723 - Ingenus Pharmaceuticals NJ, LLC. - 2015-05-04](https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-nj-llc/e4b491df-4a0c-448c-898d-abe1da1d6318) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 4, 2015
- [FDA Inspection 898420 - Ingenus Pharmaceuticals NJ, LLC. - 2014-09-29](https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-nj-llc/4b7c3d65-af98-42e1-9572-ef741d9255bc) — classification: No Action Indicated (NAI), source: FDA, date: September 29, 2014
- [FDA Inspection 852153 - Ingenus Pharmaceuticals NJ, LLC. - 2013-10-22](https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-nj-llc/53bb5010-1323-4fc4-8ebb-f740a7840ad6) — classification: No Action Indicated (NAI), source: FDA, date: October 22, 2013
- [FDA Inspection 807379 - Ingenus Pharmaceuticals NJ, LLC. - 2012-11-15](https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-nj-llc/dca7df8e-958b-4519-851f-1ca8c557b107) — classification: No Action Indicated (NAI), source: FDA, date: November 15, 2012

## Related Companies

- [Becton Dickinson Infusion Therapy Systems, Inc.](https://www.keypedia.com/companies/becton-dickinson-infusion-therapy-systems-inc/d0e73e32-eca1-4137-8dfc-d6bde32ba0aa)
- [AstraZeneca AB](https://www.keypedia.com/companies/astrazeneca-ab/b85a1aa5-9a0c-4c1e-996d-70b40b2507de)
- [Mipharm S.p.A.](https://www.keypedia.com/companies/mipharm-spa/5bbbfcd9-7f44-434e-a097-60a4d9f446bc)
- [Eisai, Inc.](https://www.keypedia.com/companies/eisai-inc/1e0d6af4-f962-4ac0-826f-90ce5f71a0a3)
- [Vee Pak, LLC](https://www.keypedia.com/companies/vee-pak-llc/db6ee2df-3da4-447c-be7a-d6c3d854af73)
- [Nostrum Laboratories, Inc.](https://www.keypedia.com/companies/nostrum-laboratories-inc/c9042755-fe46-4113-b071-6c8168af53e2)
- [Sanofi Winthrop Industrie](https://www.keypedia.com/companies/sanofi-winthrop-industrie/88a4c8ee-d792-4747-acb7-de304d1efbb6)
- [Mayne Pharma International PTY LTD](https://www.keypedia.com/companies/mayne-pharma-international-pty-ltd/073fd71d-43f6-4a53-9597-0951e7459d08)
- [Rovi Pharma Industrial Services S.A.](https://www.keypedia.com/companies/rovi-pharma-industrial-services-sa/92dc52fe-a8d7-4a23-bc34-be68892d8866)
- [Actavis Laboratories FL, Inc.](https://www.keypedia.com/companies/actavis-laboratories-fl-inc/7c50db23-6cc7-4100-bc80-c02d3aa7f85a)

## Related Officers

- [recipient](https://www.keypedia.com/people/raj-devalapalli/1e5dc365-cfa1-469b-bd2b-fbcdda48c218)
- [company_representative](https://www.keypedia.com/people/ravi-tallapragada/27a2163c-c557-4160-bf58-df2c285ad4e1)
- [Investigator](https://www.keypedia.com/people/junho-pak/4abe53fb-ad20-490d-9e71-6216a9f863f5)